Floatz logo

Apremilast

Chronic Prostatitis With Chronic Pelvic Pain Syndrome

Kenneth Peters, MDSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Chronic Prostatitis With Chronic Pelvic Pain Syndrome cohort.

Asset / SponsorPhaseRating
Serenoa repens extract
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
Selenium
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
Ningmitai
Xintian Pharmaceutical
Phase 4BB
PALMITIC MONOETHANOLAMIDE
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
Dcs
Northwestern University
Phase 4BB

View all 15 →

Same molecule, other indications

Apremilast is also rated in:

psoriasisDormant
B
Indicative ·
62 / 100
View asset →
chronic prostatitisDormant
B
Indicative ·
57 / 100
View asset →
depressive disorderDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →